This is a profile image of Jan van Overbeeke

Jan van Overbeeke

Partner, Tokyo

Helps grow and globalize pharmaceutical and medical device companies, incorporating innovations in commercial, medical affairs and advanced analytics

About

Jan is a leader of our Pharmaceutical & Medical Products Practice in Japan, and Asia more broadly, and advises global and domestic pharmaceutical and medical-device companies. He helps leadership teams across a broad range of topics, with a specific focus on portfolio strategy and commercial and medical capability building, including advanced analytics.

Examples of Jan’s previous work include the following:

  • helping a top global biopharma build up its business across Asia, including portfolio decisions, medical and commercial strategy, scaling up the organization and capability building, to accelerate the growth of its brands
  • supporting an iconic Japanese pharmaceutical company to globalize and accelerate its transformation across functions, including acceleration of multiple digital lighthouses across the business
  • helping multiple pharmaceutical and medical-device companies develop and implement market-entry and growth strategies in Japan and the rest of Asia, including deploying advanced analytics use-cases

Jan is a member of the executive leadership team of the Medical Affairs Professional Society in Asia. He supports multiple companies on their medical strategy and organization.

Born and raised in the Netherlands, where Jan also started his professional career, he later worked in the United Kingdom, and across Europe, and has been part of McKinsey Japan since 2014.

Published Work

“Simplification for success: Rewiring the biopharma operating model,” McKinsey & Company, March 2025

“COVID-19 in Pharma Commercial: Navigating an uneven recovery,” McKinsey & Company, May 2020

“Asia on the move Five trends shaping the Asia biopharmaceutical market,” McKinsey & Company, May 2018

“The evolving role of medical affairs in Asia Pacific Three imperatives for pharmacos,” McKinsey & Company, April 2018

“The digital imperative for pharma companies in Japan,” McKinsey & Company, March 2018

“The medtech opportunity for Japanese companies,” McKinsey & Company, November 2017

“Elevating the impact of medical affairs in Japan,” McKinsey & Company, October 2017

Past experience

Airbus
Graduate trainee

Education

INSEAD
MBA

Delft University of Technology
MS, aerospace engineering

Massachusetts Institute of Technology
MS, aerospace engineering

Leiden University
BA, Law

ACTIVITIES AND INTERESTS

Stichting Nederlands Onderwijs in Japan (SNOJ)
Board member